- Home
- VEEE vs VRAX Comparison
VEEE vs VRAX Comparison
Compare VEEE & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- VRAX
- Stock Information
- Founded
- VEEE 1994
- VRAX 2013
- Country
- VEEE United States
- VRAX United Kingdom
- Employees
- VEEE N/A
- VRAX N/A
- Industry
- VEEE Marine Transportation
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VEEE Industrials
- VRAX Health Care
- Exchange
- VEEE Nasdaq
- VRAX Nasdaq
- Market Cap
- VEEE 6.4M
- VRAX 5.9M
- IPO Year
- VEEE 2021
- VRAX 2022
- Fundamental
- Price
- VEEE $2.46
- VRAX $1.09
- Analyst Decision
- VEEE
- VRAX Strong Buy
- Analyst Count
- VEEE 0
- VRAX 1
- Target Price
- VEEE N/A
- VRAX $3.00
- AVG Volume (30 Days)
- VEEE 127.0K
- VRAX 300.7K
- Earning Date
- VEEE 05-14-2025
- VRAX 02-05-2025
- Dividend Yield
- VEEE N/A
- VRAX N/A
- EPS Growth
- VEEE N/A
- VRAX N/A
- EPS
- VEEE N/A
- VRAX N/A
- Revenue
- VEEE $14,388,517.00
- VRAX $84,872.00
- Revenue This Year
- VEEE N/A
- VRAX $5,169.18
- Revenue Next Year
- VEEE N/A
- VRAX $66.97
- P/E Ratio
- VEEE N/A
- VRAX N/A
- Revenue Growth
- VEEE N/A
- VRAX 7.03
- 52 Week Low
- VEEE $2.13
- VRAX $0.60
- 52 Week High
- VEEE $9.70
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- VEEE 41.40
- VRAX 48.47
- Support Level
- VEEE $2.05
- VRAX $0.91
- Resistance Level
- VEEE $2.84
- VRAX $1.09
- Average True Range (ATR)
- VEEE 0.53
- VRAX 0.11
- MACD
- VEEE -0.03
- VRAX 0.03
- Stochastic Oscillator
- VEEE 18.22
- VRAX 51.92
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.